Personal information

No personal information available

Activities

Works (22)

Pacemaker pocket infection by Nocardia carnea. First case description and literature review

Microbes and Infection
2022-06 | Journal article
Contributors: Gladys Virginia Guedez López; María Rodríguez Tejedor; Manuela De Pablos Gómez; Miguel Sánchez Castellano; Beatriz Díaz Pollán; Julen Cadiñanos Loidi; Marta Mora; Jesús Mingorance; Rosa De Miguel Buckley
Source: check_circle
Crossref

Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)

Journal of Antimicrobial Chemotherapy
2021-08-30 | Journal article
Part of ISSN: 0305-7453
Part of ISSN: 1460-2091
Source: Self-asserted source
Julen Cadiñanos

Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment

The Journal of Infectious Diseases
2021-06-24 | Journal article
Part of ISSN: 0022-1899
Part of ISSN: 1537-6613
Source: Self-asserted source
Julen Cadiñanos

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.

The lancet. HIV
2021-04-01 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

Pulmonology
2021-03 | Journal article
Part of ISSN: 2531-0437
Source: Self-asserted source
Julen Cadiñanos

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.

Thorax
2021-02-25 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Risks and benefits of reducing the number of drugs to treat HIV-1 infection.

Expert opinion on drug safety
2021-02-24 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.

The Journal of antimicrobial chemotherapy
2021-02-01 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2020-08-27 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2020-08-04 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).

EBioMedicine
2020-05-11 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Monitoring adverse events of new drugs: a programmatic need stimulating operational research.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
2020-04-01 | Journal article
Source: Self-asserted source
Julen Cadiñanos

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

International Journal of Infectious Diseases
2020-03 | Journal article
Part of ISSN: 1201-9712
Source: Self-asserted source
Julen Cadiñanos

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

European Respiratory Journal
2019-12 | Journal article
Part of ISSN: 0903-1936
Part of ISSN: 1399-3003
Source: Self-asserted source
Julen Cadiñanos
grade
Preferred source (of 2)‎

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

International Journal of Infectious Diseases
2019-06 | Journal article
Part of ISSN: 1201-9712
Source: Self-asserted source
Julen Cadiñanos
grade
Preferred source (of 2)‎

Amino-terminal pro-B-type natriuretic peptide, inferior vena cava ultrasound, and biolectrical impedance analysis for the diagnosis of acute decompensated CHF

The American journal of emergency medicine
2016 | Journal article
Source: Self-asserted source
Julen Cadiñanos

[Systemic secondary AA amyloidosis]

Medicina clinica
2015 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Usefulness of ultrasonography of inferior vena cava and bioelectrical impedance against NT-proBNP for the diagnosis of acute decompensated heart failure in an emergency department

European Journal of Heart Failure.
2015 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Endobronchial tuberculosis simulating lung cancer

Archivos de bronconeumologia
2014 | Journal article
Source: Self-asserted source
Julen Cadiñanos

NT-ProBNP, inferior vena cava ultrasonography and bioelectrical impedance analysis in dyspneic patients attended in an emergency department of a university hospital: Heart Failure patients profile.

. European Journal of Heart Failure.
2014 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Systemic AA amyloidosis: epidemiology, diagnosis, and management

Clinical epidemiology
2014 | Journal article
Source: Self-asserted source
Julen Cadiñanos

Enfermedad Renal Crónica.

Práctica Clínica en Medicina Interna.
Book chapter
Source: Self-asserted source
Julen Cadiñanos